User profiles for "author:Wolf-Dieter Vogl"
Wolf-Dieter VoglRetInSight GmbH Verified email at retinsight.com Cited by 1072 |
[HTML][HTML] AI-based monitoring of retinal fluid in disease activity and under therapy
U Schmidt-Erfurth, GS Reiter, S Riedl… - Progress in retinal and …, 2022 - Elsevier
Retinal fluid as the major biomarker in exudative macular disease is accurately visualized by
high-resolution three-dimensional optical coherence tomography (OCT), which is used …
high-resolution three-dimensional optical coherence tomography (OCT), which is used …
Characterization of drusen and hyperreflective foci as biomarkers for disease progression in age-related macular degeneration using artificial intelligence in optical …
Importance The morphologic changes and their pathognomonic distribution in progressing
age-related macular degeneration (AMD) are not well understood. Objectives To …
age-related macular degeneration (AMD) are not well understood. Objectives To …
Predicting semantic descriptions from medical images with convolutional neural networks
Learning representative computational models from medical imaging data requires large
training data sets. Often, voxel-level annotation is unfeasible for sufficient amounts of data …
training data sets. Often, voxel-level annotation is unfeasible for sufficient amounts of data …
[HTML][HTML] Application of automated quantification of fluid volumes to anti–VEGF therapy of neovascular age-related macular degeneration
U Schmidt-Erfurth, WD Vogl, LM Jampol, H Bogunović - Ophthalmology, 2020 - Elsevier
Purpose Anti–vascular endothelial growth factor (VEGF) treatment of neovascular age-
related macular degeneration (AMD) is a highly effective advance in the retinal armentarium …
related macular degeneration (AMD) is a highly effective advance in the retinal armentarium …
[HTML][HTML] Predicting topographic disease progression and treatment response of pegcetacoplan in geographic atrophy quantified by deep learning
Purpose To identify disease activity and effects of intravitreal pegcetacoplan treatment on
the topographic progression of geographic atrophy (GA) secondary to age-related macular …
the topographic progression of geographic atrophy (GA) secondary to age-related macular …
[HTML][HTML] The effect of pegcetacoplan treatment on photoreceptor maintenance in geographic atrophy monitored by artificial intelligence–based OCT analysis
Purpose To investigate the therapeutic effect of intravitreal pegcetacoplan on the inhibition
of photoreceptor (PR) loss and thinning in geographic atrophy (GA) on conventional spectral …
of photoreceptor (PR) loss and thinning in geographic atrophy (GA) on conventional spectral …
Quantification of fluid resolution and visual acuity gain in patients with diabetic macular edema using deep learning: a post hoc analysis of a randomized clinical trial
PK Roberts, WD Vogl, BS Gerendas… - JAMA …, 2020 - jamanetwork.com
Importance Large amounts of optical coherence tomographic (OCT) data of diabetic macular
edema (DME) are acquired, but many morphologic features have yet to be identified and …
edema (DME) are acquired, but many morphologic features have yet to be identified and …
[HTML][HTML] Clinical validation for automated geographic atrophy monitoring on OCT under complement inhibitory treatment
Geographic atrophy (GA) represents a late stage of age-related macular degeneration,
which leads to irreversible vision loss. With the first successful therapeutic approach, namely …
which leads to irreversible vision loss. With the first successful therapeutic approach, namely …
Analysis of fluid volume and its impact on visual acuity in the fluid study as quantified with deep learning
Purpose: To investigate quantitative differences in fluid volumes between subretinal fluid
(SRF)–tolerant and SRF-intolerant treat-and-extend regimens for neovascular age-related …
(SRF)–tolerant and SRF-intolerant treat-and-extend regimens for neovascular age-related …
Deep survival modeling of longitudinal retinal OCT volumes for predicting the onset of atrophy in patients with intermediate AMD
In patients with age-related macular degeneration (AMD), the risk of progression to late
stages is highly heterogeneous, and the prognostic imaging biomarkers remain unclear. We …
stages is highly heterogeneous, and the prognostic imaging biomarkers remain unclear. We …